ARS Pharmaceuticals And 2 Other Growth Leaders With Insider Ownership

In This Article:

As the U.S. stock market experiences a pause in its recent rally, with investors closely monitoring developments on tariffs and Federal Reserve decisions, the focus shifts to companies that can weather economic uncertainties. In this environment, growth companies with high insider ownership often stand out due to their potential alignment of interests between management and shareholders, which can be particularly appealing when navigating volatile markets.

Top 10 Growth Companies With High Insider Ownership In The United States

Name

Insider Ownership

Earnings Growth

Super Micro Computer (NasdaqGS:SMCI)

14.1%

34.1%

Hims & Hers Health (NYSE:HIMS)

13.1%

21.9%

Duolingo (NasdaqGS:DUOL)

14.3%

39%

FTC Solar (NasdaqCM:FTCI)

32.7%

65.4%

Credo Technology Group Holding (NasdaqGS:CRDO)

12.2%

65.1%

Niu Technologies (NasdaqGM:NIU)

36%

82.8%

Clene (NasdaqCM:CLNN)

19.4%

64%

Astera Labs (NasdaqGS:ALAB)

15.3%

61.4%

BBB Foods (NYSE:TBBB)

16.2%

29.9%

Upstart Holdings (NasdaqGS:UPST)

12.6%

100.2%

Click here to see the full list of 204 stocks from our Fast Growing US Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

ARS Pharmaceuticals

Simply Wall St Growth Rating: ★★★★★☆

Overview: ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for severe allergic reactions, with a market cap of approximately $1.42 billion.

Operations: The company generates revenue from its pharmaceuticals segment, amounting to $89.15 million.

Insider Ownership: 19%

Revenue Growth Forecast: 35.6% p.a.

ARS Pharmaceuticals is experiencing significant growth, with revenue jumping to US$89.15 million from just US$0.03 million the previous year, and turning profitable with a net income of US$8 million. The company recently partnered with ALK-Abello to promote neffy, an innovative needle-free epinephrine nasal spray for allergic reactions. Analysts forecast robust annual earnings growth of 52.9%, supported by expected revenue expansion of 35.6% per year, outpacing market averages.

NasdaqGM:SPRY Earnings and Revenue Growth as at May 2025
NasdaqGM:SPRY Earnings and Revenue Growth as at May 2025

Viant Technology

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Viant Technology Inc. is an advertising technology company with a market cap of approximately $914.43 million.

Operations: The company's revenue primarily comes from its Internet Information Providers segment, which generated $289.24 million.